CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020. Fourth Quarter ...
The COVID-19 pandemic upended mental health and substance abuse treatment programs across the country. In Gainesville, a new report from Meridian Behavioral Healthcare details how treatment via ...
Fourth Quarter Fiscal 2020 Results (Comparison to Fourth Quarter Fiscal 2019)Consolidated revenue for the fourth quarter of fiscal 2020 increased 26% to $64.2 million, compared to $50.8 million last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results